(Q47583196)

4 February 2018

title

New clinical concepts after the ONTARGET trial (English)

1 reference

4 February 2018

author

Julian Segura

series ordinal

2

1 reference

4 February 2018

Luis Miguel Ruilope

object named as

Luis M Ruilope

series ordinal

1

0 references

author name string

Jose L Zamorano

series ordinal

3

1 reference

4 February 2018

publication date

1 June 2011

1 reference

4 February 2018

Expert Review of Cardiovascular Therapy

published in

1 reference

4 February 2018

volume

9

1 reference

4 February 2018

issue

6

1 reference

4 February 2018

page(s)

685-689

1 reference

4 February 2018

Telmisartan, ramipril, or both in patients at high risk for vascular events

cites work

1 reference

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

Angiotensin-converting-enzyme inhibition in stable coronary artery disease

21 January 2018

1 reference

2007 Guidelines for the Management of Arterial Hypertension

21 January 2018

1 reference

Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study

21 January 2018

1 reference

Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease

21 January 2018

1 reference

Effects of intensive blood-pressure control in type 2 diabetes mellitus

21 January 2018

1 reference

Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document

21 January 2018

1 reference

Ischemic stroke in South Asians: a review of the epidemiology, pathophysiology, and ethnicity-related clinical features

21 January 2018

1 reference

Telmisartan to prevent recurrent stroke and cardiovascular events

21 January 2018

1 reference

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

21 January 2018

1 reference

Antihypertensive treatment in patients with type-2 diabetes mellitus: what guidance from recent controlled randomized trials?

21 January 2018

1 reference

Predictors of blood pressure response to intensified and fixed combination treatment of hypertension: the ACCOMPLISH study

21 January 2018

1 reference

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.

21 January 2018

1 reference

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

Intensive Blood-Pressure Control in Hypertensive Chronic Kidney Disease

21 January 2018

1 reference

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

21 January 2018

1 reference

Eplerenone in patients with systolic heart failure and mild symptoms

21 January 2018

1 reference

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials

21 January 2018

1 reference

How should we manage heart failure developing in patients already treated with angiotensin-converting enzyme inhibitors and beta-blockers for hypertension, diabetes or coronary disease?

21 January 2018

1 reference

Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes

21 January 2018

1 reference

Cardiovascular and mortality risk prediction and stratification using urinary albumin excretion in older adults ages 68–102: The cardiovascular Health Study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERC.11.52

1 reference

4 February 2018

1 reference

4 February 2018